Natural killer cells in non-hematopoietic malignancies

Frontiers in Immunology

Volumn 3, Issue DEC, 2012, Pages

  Desbois, Melanie ^a,b   Rusakiewicz, Sylvie ^a   Locher, Clara ^a,b   Zitvogel, Laurence ^a,b   Chaput, Nathalie ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Environment; Maturation stage; Metastases; NK cells; Tumors

Indexed keywords

EID: 84874313014     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00395     Document Type: Review

References (133)

1. Aboud, M., Kingsmore, S., and Segal, S. (1993). Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones. Nat. Immunol 12, 17-24.
2. Al-Shibli, K., Al-Saad, S., Donnem, T., Persson, M., Bremnes, R. M., and Busund, L. T. (2009). The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. Histopathology 55, 301-312.
3. Balachandran, V. P., Cavnar, M. J., Zeng, S., Bamboat, Z. M., Ocuin, L. M., Obaid, H., etal. (2011). Ima-tinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nat.Med. 17, 1094-1100.
4. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., etal. (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729.
5. Beilke, J. N., Kuhl, N. R., Van Kaer, L, and Gill, R. G. (2005). NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat. Med. 11, 1059-1065.
6. Bidwell, B. N., Slaney, C. Y., Withana, N. P., Forster, S., Cao, Y., Loi, S., etal. (2012). Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. doi: 10.1038/nm.2830 [Epub ahead of print].
7. Blackhall, E H., Merry, C. L, Davies, E. J., and Jayson, G. C. (2001). Heparan sulfate proteoglycans and cancer. Br. I Cancer 85,1094-1098.
8. Bloushtain, N., Qimron, U., Bar-Ilan, A., Hershkovitz, O., Gazit, R., Fima, E., etal. (2004). Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46./. Immunol. 173,2392-2401.
9. Borg, C, Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Char-rier, S., etal. (2004). NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104, 3267-3275.
10. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., etal. (1998). HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799.
11. Burt, B. M., Plitas, G., Stableford, J. A., Nguyen, H. M., Bamboat, Z. M., Pil-larisetty, V. G., etal. (2008). CDllc identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. Leukoc. Biol 84, 1039-1046.
12. Cagnano, E., Hershkovitz, O., Zilka, A., Bar-Ilan, A., Golder, A., Sion-Vardy, N., etal. (2008). Expression of lig-ands to NKp46 in benign and malignant melanocytes./. Invest. Dermatol. 128, 972-979.
13. Cameron, S., Haller, E, Dudas, J., Moriconi, E, Gunawan, B., Arm-brust, T., etal. (2008). Immune cells in primary gastrointestinal stromal tumors. Eur. J. Gastroenterol Hepatol 20, 327-334.
14. Campbell, J. J., Qin, S., Unutmaz, D., Soler, D., Murphy, K. E., Hodge, M. R., etal. (2001). Unique subpop-ulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166, 6477-6482.
15. Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., etal. (2008). Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. Cancer 112,863-875.
16. Cella, M., Fuchs, A., Vermi, W., Fac-chetti, E, Otero, K., Lennerz, J. K., etal. (2009). A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725.
17. Chan, C. W., Crafton, E., Fan, H. N., Flook, J., Yoshimura, K., Skarica, M., etal. (2006). Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12, 207-213.
18. Chiossone, L., Chaix, J., Fuseri, N., Roth, C, Vivier, E., and Walzer, T. (2009). Maturation of mouse NK cells is a 4-stage developmental program. Blood 113,5488-5496.
19. Chow, M. T., Sceneay, J., Paget, C, Wong, C. S., Duret, H., Tschopp, J., et al. (2012). NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res. 72, 5721-5732.
20. Colonna, M. (2009). Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31, 15-23.
21. Cooper, M. A., Fehniger, T. A., and Caligiuri, M. A. (2001). The biology of human natural killer-cell subsets. Trends Immunol 22, 633-640.
22. Cosman, D., Mullberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., etal. (2001). ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133.
23. Das, B., Tsuchida, R., Malkin, D., Koren, G., Baruchel, S., and Yeger, H. (2008). Hypoxia enhances tumor sternness by increasing the invasive and tumori-genic side population fraction. Stem Cells26, 1818-1830.
24. De Maria, A., Bozzano, E, Can-toni, C, and Moretta, L. (2011). Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc. Natl. Acad. Sci. U.S.A. 108, 728-732.
25. Delahaye, N. E, Rusakiewicz, S., Martins, I., Menard, C, Roux, S., Lyonnet, L., etal. (2011). Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat. Med. 17,700-707.
26. Diefenbach, A., Jensen, E. R., Jamieson, A. M., and Raulet, D. H. (2001). Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413,165-171.
27. Doherty, D. G., and O'Farrelly, C. (2000). Innate and adaptive lymphoid cells in the human liver. Immunol Rev. 174,5-20.
28. Dunn, C, Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., etal. (2007). Cytokines induced during chronic hepatitis B virus infection promotea pathway for NK cell-mediated liver damage. J. Exp. Med. 204, 667-680.
29. Ebata, K., Shimizu, Y, Nakayama, Y, Minemura, M., Murakami, J., Kato, T., etal. (2006). Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model. J. Immunol 176, 4113-4124.
30. Ebert, L. M., Meuter, S., and Moser, B. (2006). Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J. Immunol 176, 4331-4336.
31. Eckhardt, B. L., Parker, B. S., Van Laar, R. K., Restall, C. M., Natoli, A. L, Tavaria, M. D., etal. (2005). Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol. Cancer Res. 3, 1-13.
32. Erdag, G., Schaefer, J. T., Smolkin, M. E., Deacon, D. H., Shea, S. M., Dengel, L. T., etal. (2012). Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res. 72, 1070-1080.
33. Fauriat, C, Long, E. O., Ljunggren, H. G., and Bryceson, Y T. (2010). Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115, 2167-2176.
34. Ferlazzo, G., Thomas, D., Lin, S. L., Goodman, K., Morandi, B., Muller, W. A., etal. (2004). The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol 172, 1455-1462.
35. Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, E, etal. (2003). MICA/NKG2D-mediated immunogene therapy of experimental gliomas. Cancer Res. 63, 8996-9006.
36. Gannon, P. O., Poisson, A. O., Delvoye, N., Lapointe, R., Mes-Masson, A. M., and Saad, E (2009). Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients. J. Immunol Methods 348, 9-17.
37. Glas, R., Franksson, L., Une, C, Elo-ranta, M. L., Ohlen, C, Orn, A., et al. (2000). Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell pheno-type. An adaptive component of NK cell-mediated responses. J. Exp. Med. 191,129-13
38. Glas, R., Sturmhofel, K., Hammer-ling, G. J., Karre, K., and Ljung-gren, H. G. (1992). Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells. J. Exp. Med. 175, 843-846.
39. Gorelik, E., Wiltrout, R. H., Okumura, K., Habu, S., and Herberman, R. B. (1982). Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int. J. Cancer 30,107-112.
40. Groh, V., Bahrain, S., Bauer, S., Herman, A., Beauchamp, M., and Spies, T. (1996). Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 93,12445-12450.
41. Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, E, Xiong, N., etal. (2008). NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy, immunity 28, 571-580.
42. Guimont-Desrochers, F., Boucher, G., Dong, Z., Dupuis, M., Veillette, A., and Lesage, S. (2012). Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation. Blood 119, 4349-4357.
43. Gulubova, M., Manolova, I., Kyurkchiev, D., Julianov, A., and Altunkova, I. (2009). Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases. APMIS 117, 870-879.
44. Halama, N., Braun, M., Kahlert, C, Spille, A., Quack, C, Rahbari, N., etal. (2011). Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin. Cancer Res. 17, 678-689.
45. Hayakawa, Y., and Smyth, M. J. (2006). CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol 176, 1517-1524.
46. Hayashi, T., Imai, K., Morishita, Y, Hayashi, I., Kusunoki, Y, and Nakachi, K. (2006). Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res. 66, 563-570.
47. Hecht, M. L., Rosental, B., Horlacher, T., Hershkovitz, O., De Paz, J. L, Noti, C, etal. (2009). Natural cyto-toxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sul-fate/heparin sequences. J. Proteome Res. 8, 712-720.
48. Heddleston, J. M., Li, Z., Mclendon, R. E., Hjelmeland, A. B., and Rich, J. N. (2009). The hypoxic microenviron-ment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8, 3274-3284.
49. Hershkovitz, O., Jarahian, M., Zilka, A., Bar-Ilan, A., Landau, G., Jivov, S., etal. (2008). Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunore-ceptors as an immunological tool. Glycobiology 18, 28-41.
50. Hershkovitz, O., Jivov, S., Bloushtain, N., Zilka, A., Landau, G., Bar-Ilan, A., etal. (2007). Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry 46, 7426-7436.
51. Hiby, S. E., Walker, J. J., O'Shaughnessy K, M., Redman, C. W., Carrington, M., Trowsdale, J., etal. (2004). Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957-965.
52. Imai, K., Matsuyama, S., Miyake, S., Suga, K., and Nakachi, K. (2000). Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356,1795-1799.
53. Izawa, S., Kono, K., Mimura, K., Kawaguchi, Y., Watanabe, M., Maruyama, T., etal. (2011). H(2)O(2) production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction. Cancer Immunol. Immunother. 60, 1801-1810.
54. Jarahian, M., Fiedler, M., Cohnen, A., Djandji, D., Hammerling, G. J., Gati, C, etal. (2011). Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxvi-ral hemagglutinin. PLoS Pathog. 7:el002195. doi: 10.1371/joumal. ppat.1002195
55. Jayson, G. C, Lyon, M., Paraskeva, C, Turnbull, J. E., Deakin, J. A., and Gallagher, J. T. (1998). Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J. Biol. Chem. 273, 51-57.
56. Jewett, A., and Tseng, H. C. (2011). Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells. J. Cancer 2, 443-457.
57. Jewett, A., Tseng, H. C, Arasteh, A., Saadat, S., Christensen, R. E., and Cacalano.N. A. (2012). Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells. Curr. Drug Deliv. 9, 5-16.
58. Karre, K., Ljunggren, H. G., Piontek, G., and Kiessling, R. (1986). Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678.
59. Kelly, J. M., Darcy, P. K., Markby, J. L, Godfrey, D. I., Takeda, K., Yagita, H., etal. (2002). Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3, 83-90.
60. Kim, S., Iizuka, K., Kang, H. S., Dokun, A., French, A. R., Greco, S., etal. (2002). In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3, 523-528.
61. Koh, C. Y, Blazar, B. R., George, T., Welniak, L. A., Capitini, C. M., Raz-iuddin, A., etal. (2001). Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood 97, 3132-3137.
62. Kreisel, D., Gelman, A. E., Higashikubo, R., Lin, X., Vikis, H. G., White, J. M.,etal. (2012). Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer. Cancer Res. 72, 4311-4317.
63. Ksienzyk, A., Neumann, B., Nandaku-mar, R., Finsterbusch, K., Grashoff, M., Zawatzky, R., etal. (2011). IRF-1 expression is essential for natural killer cells to suppress metastasis. Cancer Res. 71, 6410-6418.
64. Lakshmikanth, T., Burke, S., AH, T. H., Kimpfler, S., Ursini, F., Ruggeri, L., etal. (2009). NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J. Clin. Invest. 119, 1251-1263.
65. Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R., and Phillips, J. H. (1986). The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136, 4480-4486.
66. Lelekakis, M., Moseley, J. M., Martin, T. J., Hards, D., Williams, E., Ho, P., et al.(1999). A novel orthotopic model of breast cancer metastasis to bone. Clin. Exp. Metastasis 17, 163-170.
67. Liu, C, Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R., etal. (2007). Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109,4336-4342.
68. Ljunggren, H. G., and Karre, K. (1985). Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162, 1745-1759.
69. Luci, C, Reynders, A., Ivanov, I. I., Cognet, C, Chiche, L., Chasson, L., etal. (2009). Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10,75-82.
70. Mamessier, E., Sylvain, A., Bertucci, E, Castellano, R., Finetti, P., Houve-naeghel, G., etal. (2011a). Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition. Cancer Res. 71,6621-6632.
71. Mamessier, E., Sylvain, A., Thibult, M. L., Houvenaeghel, G., Jacquemier, J., Castellano, R., etal. (2011b). Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J. Clin. Invest. 121,3609-3622.
72. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715.
73. Marechal, R., De Schutter, J., Nagy, N., Demetter, P., Lemmers, A., Deviere, J., etal. (2010). Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients. BMC Cancer 10:340. doi: 10.1186/1471-2407-10-340
74. Mauti, L. A., Le Bitoux, M. A., Baumer, K., Stehle, J. C, Golshayan, D., Provero, P., etal. (2011). Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation./. Clin. Invest. 121,2794-2807.
75. Menard, C, Blay, J. Y, Borg, C, Michiels, S., Ghiringhelli, F., Robert, C, etal. (2009). Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients. Cancer Res. 69,3563-3569.
76. Menon, A. G., Janssen-Van Rhijn, C. M., Morreau, H., Putter, H., Tollenaar, R. A., Van De Velde, C. J., etal. (2004). Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab. Invest 84,493-50
77. Moretta, A., Bottino, C, Vitale, M., Pende, D., Biassoni, R., Mingari, M. C, etal. (1996). Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14, 619-648.
78. Noval Rivas, M., Hazzan, M., Weath-erly, K., Gaudray, E, Salmon, I., and Braun, M. Y. (2010). NK cell regulation of CD4 T cell-mediated graft-versus-host disease. J. Immunol. 184,6790-6798.
79. Ochi, M., Ohdan, H., Mitsuta, H., Onoe, T., Tokita, D., Hara, H., etal. (2004). Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 39, 1321-1331.
80. Pachynski, R. K., Zabel, B. A., Kohrt, H. E., Tejeda, N. M., Monnier, J., Swanson, C. D., etal. (2012). The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. J. Exp. Med. 209,1427-1435.
81. Parham, P. (2004). NK cells and tro-phoblasts: partners in pregnancy. J. Exp. Med. 200,951-955.
82. Park, M. H., Lee, J. S., and Yoon, J. H. (2012). High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. J. Surg. Oncol. 106, 386-392.
83. Parolini, S., Santoro, A., Marcenaro, E., Luini, W., Massardi, L., Facchetti, F., etal. (2007). The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109, 3625-3632.
84. Paust, S., Gill, H. S., Wang, B. Z., Flynn, M. P., Moseman, E. A., Sen-man, B., etal. (2010). Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11, 1127-1135.
85. Pende, D., Rivera, P., Marcenaro, S., Chang, C. C, Biassoni, R., Conte, R., etal. (2002). Major histocompat-ibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 62, 6178-6186.
86. Perona-Wright, G., Mohrs, K., Szaba, F. M., Kummer, L. W, Madan, R., Karp, C. L., etal. (2009). Systemic but not local infections elicit immunosup-pressive IL-10 production by naturalkiller cells. Cell Host Microbe 6, 503-512.
87. Pillarisetty, V. G., Katz, S. C, Bleier, J. I., Shah, A. B., and Dematteo, R. P. (2005). Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12. J. Immunol. 174, 2612-2618.
88. Platonova, S., Cherfils-Vicini, J., Damotte, D., Crozet, L., Vieillard, V., Validire, P., etal. (2011). Profound coordinated alterations of intratu-moral NK cell phenotype and function in lung carcinoma. Cancer Res. 71,5412-5422.
89. Plitas, G., Chaudhry, U. I., Kingham, T. P., Raab, J. R., and Dematteo, R. P. (2007). NK dendritic cells are innate immune responders to Listeria mono-cytogenes infection. J. Immunol. 178, 4411-4416.
90. Pogge von Strandmann, E., Simhadri, V. R., Von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., etal. (2007). Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27, 965-974.
91. Polyak, K., and Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273.
92. Raimondi, C, Gianni, W., Cortesi, E., and Gazzaniga, P. (2010). Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. Curr. Cancer Drug Targets 10,496-508.
93. Rosental, B., Brusilovsky, M., Hadad, U., Oz, D., Appel, M. Y., Afergan, E, etal. (2011). Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J. Immunol. 187, 5693-5702.
94. Sandel, M. H., Speetjens, F. M., Menon, A. G., Albertsson, P. A., Basse, P. H., Hokland, M., etal. (2005). Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol. Immunol. 42, 541-546.
95. Santoni, A., Zingoni, A., Cerboni, C, and Gismondi, A. (2007). Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells. Am. J. Reprod. Immunol. 58, 280-288.
96. Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, E, etal. (2008). Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958-970.
97. Sceneay, J., Chow, M. T., Chen, A., Halse, H. M., Wong, C. S., Andrews, D. M., etal. (2012). Primary tumor hypoxia recruits CDllb+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 72, 3906-3911.
98. Schulthess, J., Meresse, B., Ramiro-Puig, E., Montcuquet, N., Darche, S., Begue, B., etal. (2012). Interleukin-15-dependent NKp46+ innate lym-phoid cells control intestinal inflammation by recruiting inflammatory monocytes. Immunity 37,108-121.
99. Sconocchia, G., Arriga, R., Tornillo, L., Terracciano, L., Ferrone, S., and Spagnoli, G. C. (2012). Melanoma cells inhibit NK cell functions - letter. Cancer Res. 72, 5428-5429.
100. Sconocchia, G., Spagnoli, G. C, Del Principe, D., Ferrone, S., Anselmi, M., Wongsena, W, etal. (2009). Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia 11, 662-671.
101. Sconocchia, G., Zlobec, I., Lugli, A., Cal-abrese, D., Iezzi, G., Karamitopoulou, E., etal. (2010). Tumor infiltration by FcgammaRIII (CD 16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int.]. Cancer 128, 2663-2672.
102. Shi, F. D., Ljunggren, H. G., La Cava, A., and Van Kaer, L. (2011). Organ-specific features of natural killer cells. Nat. Rev. Immunol. 11, 658-671.
103. Silva, A., Andrews, D. M., Brooks, A. G., Smyth, M. J., and Hayakawa, Y. (2008). Application of CD27 as a marker for distinguishing human NK cell subsets. Int. Immunol. 20, 625-630.
104. Simhadri, V R., Reiners, K. S., Hansen, H. P., Topolar, D., Simhadri, V L., Nohroudi, K., etal. (2008). Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS ONE 3:e3377. doi: 10.1371/jour-nal.pone.0003377
105. Smyth, M. J., Crowe, N. Y, and Godfrey, D. I. (2001). NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int Immunol. 13,459-463.
106. Smyth, M. J., Thia, K. Y, Street, S. E., Macgregor, D., Godfrey, D. I., and Trapani, J. A. (2000). Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lym-phoma./. Exp. Med. 192, 755-760.
107. Spits, H., and Di Santo, J. P. (2011). The expanding family of innate lym-phoid cells: regulators and effectorsof immunity and tissue remodeling. Nat. Immunol. 12, 21-27.
108. Stegmann, K. A., Bjorkstrom, N. K., Veber, H., Ciesek, S., Riese, P., Wie-gand, J., etal. (2010). Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 138, 1885-1897.
109. Stoimenov, I., and Helleday, T. (2009). PCNA on the crossroad of cancer. Biochem. Soc. Trans. 37, 605-613.
110. Street, S. E., Cretney, E., and Smyth, M. J. (2001). Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood 97, 192-197.
111. Taieb, J., Chaput, N., Menard, C, Apetoh, L., Ullrich, E., Bonmort, M., etal. (2006). A novel dendritic cell subset involved in tumor immuno-surveillance. Nat. Med. 12,214-219.
112. Takanami, I., Takeuchi, K., and Giga, M. (2001). The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J. Tho-rac. Cardiovasc. Surg. 121, 1058-1063.
113. Takeda, K., Cretney, E., Hayakawa, Y, Ota, T., Akiba, H., Ogasawara, K., etal. (2005). TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105,2082-2089.
114. Takeda, K., Nakayama, M., Sakaki, M., Hayakawa, Y, Imawari, M., Ogasawara, K., etal. (2011). IFN-gamma production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice. J. Leukoc. Biol. 90, 777-785.
115. Talmadge, J. E., Meyers, K. M., Prieur, D. J., and Starkey, J. R. (1980). Role of NK cells in tumour growth and metastasis in beige mice. Nature 284, 622-624.
116. Terme, M., Mignot, G., Ullrich, E., Bonmort, M., Minard-Colin, V, Jacquet, A., etal. (2009). The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CDllb+ subset and are licensed by tumor cells. Cancer Res. 69, 6590-6597.
117. Terme, M., Ullrich, E., Aymeric, L., Meinhardt, K., Coudert, J. D., Des-bois, M., etal. (2012). Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells. Cancer Res. 72,2757-2767.
118. Tseng, H. C, Arasteh, A., Paran-jpe, A., Teruel, A., Yang, W., Behel, A., etal. (2010). Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or repro-gramming activates NK cells. PLoSONE 5:ell590. doi: 10.1371/jour-nal.pone.00115
119. Tu, Z., Bozorgzadeh, A., Pierce, R. H., Kurtis, J., Crispe, I. N., and Orloff, M. S. (2008). TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 205, 233-244.
120. van Zijl, E, Zulehner, G., Petz, M., Schneller, D., Kornauth, C, Hau, M., etal. (2009). Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 5, 1169-1179.
121. Vanderkerken, K., Bouwens, L., De Neve, W., Van Den Berg, K., Baeke-land, M., Delens, N., etal. (1993). Origin and differentiation of hepatic natural killer cells (pit cells). Hepatobgy 18, 919-925.
122. Vetter, C. S., Groh, V., Thor Straten, P., Spies, T., Brocker, E. B., and Becker, J. C. (2002). Expression of stress-induced MHC class I related chain molecules on human melanoma. J. Invest. Dermatol 118, 600-605.
123. Villegas, E R., Coca, S., Villarrubia, V. G., Jimenez, R., Chillon, M. J., Jareno, J., etal. (2002). Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer 35, 23-28.
124. Vivier, E., Ugolini, S., Blaise, D., Cha-bannon, C, and Brossay, L. (2012). Targeting natural killer cells and natural killer T cells in cancer. Nat. Rev. Immunol. 12, 239-252.
125. Vossen, M. T., Matmati, M., Hertoghs, K. M., Baars, P. A., Gent, M. R., Leclercq, G., etal. (2008). CD27 defines phenotypically and functionally different human NK cell subsets. J. Immunol. 180,3739-3745.
126. Vosshenrich, C. A., Garcia-Ojeda, M. E., Samson-Villeger, S. I., Pasqualetto, V., Enault, L, Richard-Le Goff, O., etal. (2006). A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD 127. Nat. Immunol. 7, 1217-1224.
127. Vosshenrich, C. A., Lesjean-Pottier, S., Hasan, M., Richard-Le Goff, O., Corcuff, E., Mandelboim, O., etal. (2007). CDllcloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med. 204,2569-2578.
128. Watson, N. E, Spendlove, I., Madjd, Z., Mcgilvray, R., Green, A. R., Ellis, I. O., etal. (2006). Expression of the stress-related MHC class I chain-related protein MICA is anindicator of good prognosis in col-orectal cancer patients. Int. J. Cancer 118,1445-1452.
129. Whitelaw, P. E, and Croy, B. A. (1996). Granulated lymphocytes of pregnancy. Placenta 17, 533-543.
130. Wittamer, V, Franssen, J. D., Vul-cano, M., Mirjolet, J. E, Le Poul, E., Migeotte, I., etal. (2003). Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198, 977-985.
131. Yu, Y., Ramena, G., and Elble, R. C. (2012). The role of cancer stem cells in relapse of solid tumors. Front. Biosci. (Elite Ed.) A, 1528-1541.
132. Zabel, B. A., Silverio, A. M., and Butcher, E. C. (2005). Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plas-macytoid from myeloid dendritic cells in human blood. J. Immunol. 174,244-251.
133. Zhou, R., Wei, H., and Tian, Z. (2007). NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice. J. Immunol. 178,2141-2147.